Search Results

Filter
  • 1-10 of  113 results for ""Cobicistat""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Interaction of CYP3A4 with the inhibitor cobicistat: Structural and mechanistic insights and comparison with ritonavir.

  • Authors : Sevrioukova IF; Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, 92697-3900, USA. Electronic address: .

Subjects: Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/chemistry ; Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/metabolism ; Ritonavir*/Ritonavir*/Ritonavir*/chemistry

  • Source: Archives of biochemistry and biophysics [Arch Biochem Biophys] 2024 Aug; Vol. 758, pp. 110071. Date of Electronic Publication: 2024 Jun 22.Publisher: Elsevier Country of Publication: United States NLM ID: 0372430 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Chemo-metric assisted UV-spectrophotometric methods for simultaneous estimation of Darunavir ethanolate and Cobicistat in binary mixture and their tablet formulation.

  • Authors : Devi Singh V; Noida Institute of Engineering and Technology (Pharmacy Institute), 19, Knowledge Park-II, Greater Noida, Uttar Pradesh 201306, India. Electronic address: .; Kumar Singh V

Subjects: Cobicistat* ; HIV Infections*; Darunavir

  • Source: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2021 Apr 05; Vol. 250, pp. 119383. Date of Electronic Publication: Publisher: Elsevier Country of Publication: England NLM ID: 9602533 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Acute Ischemia of Lower Extremities Caused by Ergotamine Toxicity due to Pharmacologic Interaction With Cobicistat in an HIV-Positive Patient.

Subjects: Adrenergic alpha-1 Receptor Agonists/Adrenergic alpha-1 Receptor Agonists/Adrenergic alpha-1 Receptor Agonists/*adverse effects ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*adverse effects ; Cobicistat/Cobicistat/Cobicistat/*adverse effects

  • Source: Annals of vascular surgery [Ann Vasc Surg] 2022 Mar; Vol. 80, pp. 392.e1-392.e6. Date of Electronic Publication: 2021 Nov 11.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8703941 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Ritonavir/Cobicistat-Induced Cushing Syndrome in HIV Patients Treated With Non-Oral Corticosteroids: A Call for Action?

  • Authors : Cattaneo D; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Gestione Ambulatoriale Politerapie (GAP) outpatient clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

Subjects: Adrenal Cortex Hormones/Adrenal Cortex Hormones/Adrenal Cortex Hormones/*adverse effects ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*adverse effects ; Cobicistat/Cobicistat/Cobicistat/*adverse effects

  • Source: The American journal of the medical sciences [Am J Med Sci] 2021 Jan; Vol. 361 (1), pp. 137-139. Date of Electronic Publication: 2020 Aug 10.Publisher: Elsevier Country of Publication: United States NLM ID: 0370506 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

No Inhibition of MATE1/2K-Mediated Renal Creatinine Secretion Predicted With Ritonavir or Cobicistat.

  • Authors : Kikuchi R; Drug Metabolism and Pharmacokinetics-Translational Modeling, AbbVie Inc., North Chicago, Illinois 60064. Electronic address: .; Chiou WJ

Subjects: Cobicistat/Cobicistat/Cobicistat/*pharmacology ; Creatinine/Creatinine/Creatinine/*metabolism ; Organic Cation Transport Proteins/Organic Cation Transport Proteins/Organic Cation Transport Proteins/*antagonists & inhibitors

  • Source: Journal of pharmaceutical sciences [J Pharm Sci] 2019 Sep; Vol. 108 (9), pp. 3118-3123. Date of Electronic Publication: 2019 Apr 26.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma.

  • Authors : Penchala SD; Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK. Electronic address: .; Fawcett S

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*blood ; Chromatography, High Pressure Liquid/Chromatography, High Pressure Liquid/Chromatography, High Pressure Liquid/*methods ; Cobicistat/Cobicistat/Cobicistat/*blood

  • Source: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2016 Aug 01; Vol. 1027, pp. 174-80. Date of Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.

  • Authors : Gallucci L; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.; Bazire J

Subjects: Coronavirus Infections*/Coronavirus Infections*/Coronavirus Infections*/drug therapy ; Middle East Respiratory Syndrome Coronavirus*; Humans

  • Source: Antiviral research [Antiviral Res] 2024 Jan; Vol. 221, pp. 105766. Date of Electronic Publication: 2023 Nov 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial.

  • Authors : Trujillo-Rodríguez M; Enfermedades Infecciosas, Microbiología Clínica y Medicina Preventiva, Instituto de Biomedicina de Sevilla/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain.; Muñoz-Muela E

Subjects: Anti-HIV Agents* ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy; Adult

  • Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2022 Aug; Vol. 28 (8), pp. Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

A 28-Year-Old Man With Diffuse Bilateral Pulmonary Nodules.

  • Authors : Pokhrel K; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, NY. Electronic address: .; Barry S

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/complications ; HIV Infections*/HIV Infections*/HIV Infections*/diagnosis

  • Source: Chest [Chest] 2022 Jul; Vol. 162 (1), pp. e9-e13.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Subjects: Adenine/Adenine/Adenine/*analogs & derivatives ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Carbamates/Carbamates/Carbamates/*administration & dosage

  • Source: Lancet (London, England) [Lancet] 2015 Jun 27; Vol. 385 (9987), pp. 2606-15. Date of Electronic Publication: 2015 Apr 15.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  113 results for ""Cobicistat""